All News

    SIRT With 90Y Resin Microspheres Provides Benefit in GIST Liver Metastases

    April 29th 2025, 1:00pm

    Article

    SIRT with 90Y resin microspheres led to durable disease control in patients with gastrointestinal stromal tumor liver metastases resistant to TKI therapy.

    Alternating Glivec and Stivarga Doesn't Improve Advanced GIST Outcomes

    April 28th 2025, 9:00pm

    Article

    Alternating between Glivec and Stivarga therapy didn't impact survival outcomes; it led to more toxicity and discontinuations in patients with GIST.

    Breast MRI Offers Sensitive Imaging for High-Risk and Diagnosed Patients

    April 28th 2025, 8:00pm

    Video

    Breast MRI helps doctors detect disease in newly diagnosed and high-risk patients without replacing mammograms, according to an expert.

    Neoadjuvant Mitomycin C Shows Favorable Safety in Bladder Cancer

    April 28th 2025, 7:00pm

    Article

    Among patients with non–muscle-invasive bladder cancer, neoadjuvant mitomycin demonstrated favorable safety.

    How Mammogram Reminders Can Be More Thoughtful Following Breast Cancer

    April 28th 2025, 5:00pm

    Article

    I reflect on how a generic mammogram reminder overlooked my experience as a breast cancer survivor and how thoughtful messaging could make a difference.

    TAR-200 Achieves High DFS and Bladder Preservation Rates in Bladder Cancer Subgroups

    April 28th 2025, 4:00pm

    Article

    TAR-200 demonstrated a high disease-free survival and bladder preservation rates in BCG-unresponsive, high-risk non-muscle-invasive bladder cancer.

    Zongertinib Elicits Responses in HER2-Mutant NSCLC

    April 28th 2025, 3:00pm

    Article

    Zongertinib elicited meaningful results in previously treated patients with HER2-mutated, advanced non–small cell lung cancer.

    How an Advocate Unites Voices to Guide MPN Research Decisions

    April 28th 2025, 1:00pm

    Video

    Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.

    Healer, Mentor and Leader

    April 27th 2025, 6:00pm

    Article

    Reflecting upon my relationship with Jill over the past 25 years, I am in awe of all she has accomplished.

    Treatment With HT-KIT Shows Early Preclinical Activity in GIST Models

    April 27th 2025, 6:00pm

    Article

    HT-KIT, a novel targeted therapy for GIST, demonstrated the ability to reduce tumor burden in humanized mouse models and induce tumor cell death.